Zoltias MD 0.25 Tablet
Marketer
Matias Healthcare Pvt Ltd
Salt Composition
Etizolam (0.25mg)
Overview Zoltias MD 0.25 Tablet
Prescribed for brief anxiety and sleeplessness, the 0.25mg Zoltias MD tablet acts on specific brain receptors to induce calmness and relaxation. This medication can be ingested with or without food, but consistent daily timing ensures stable blood levels. Always adhere to your physician's prescribed dosage and duration, as dependency is a significant risk. Missed doses should be taken promptly, completing the entire course regardless of symptom improvement. Abrupt cessation requires medical consultation, potentially triggering nausea and anxiety. Headaches, motor skill impairment, slurred speech, muscle weakness, altered sex drive, and depression are possible side effects. Drowsiness and dizziness may occur; avoid activities demanding concentration until the drug's effects are understood. Discuss potential side effects and management strategies with your doctor; withdrawal symptoms may also arise. Inform your physician of pregnancy, pregnancy plans, or breastfeeding before commencing treatment. While generally compatible with other medications, interactions exist with certain drugs, including antacids and alcohol, potentially increasing adverse reactions. Long-term use may necessitate regular blood and liver function monitoring.
Uses of Zoltias MD 0.25 Tablet
Managing acute anxiety and sleeplessness
Major Benefits of Zoltias MD 0.25 Tablet:
Administer this medication according to your physician's prescribed dosage and schedule. Avoid handling the tablets with damp hands. Place the tablet in your mouth, but refrain from swallowing immediately. Zoltias MD 0.25 Tablet can be ingested with or without food, although consistent timing is recommended.
Common Side effects of Zoltias MD 0.25 Tablet:
- Altered libido
- Confusion
- Depression
- Drowsiness
- Fainting
- Headache
- Muscle coordination impaired
- Muscle weakness
- Sedation
- Slurred speech
- Tremors
- Visual impairment
How to use Zoltias MD 0.25 Tablet:
Administer this medication precisely as prescribed by your physician, adhering to both dosage and treatment length. Avoid contact with the tablets using damp hands. Place the Zoltias MD 0.25 Tablet in your mouth for dissolution; do not ingest it whole. Consumption with or without food is acceptable; however, consistent daily timing is recommended.
How Zoltias MD 0.25 Tablet works:
Zoltias MD 0.25mg tablets contain a benzodiazepine that enhances the effects of GABA, a neurotransmitter. This action reduces heightened, irregular neuronal firing in the brain.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Zoltias MD 0.25 Tablet may pose unknown risks. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Data on the use of Zoltias MD 0.25 Tablet in pregnancy is lacking. Seek medical advice from your physician.
Breast feedingCONSULT YOUR DOCTOR
Data on Zoltias MD 0.25 Tablet use while breastfeeding is absent. Seek medical advice.
DrivingUNSAFE
Driving ability may be compromised by Zoltias MD 0.25 Tablet, which can produce side effects. Sedation and musculoskeletal relaxation are frequently reported side effects of Zoltias MD 0.25 Tablet.
KidneyCONSULT YOUR DOCTOR
Data on Zoltias MD 0.25 Tablet use in individuals with renal impairment is scarce. Physician consultation is advised.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding Zoltias MD 0.25 Tablet use in individuals with hepatic impairment. Physician consultation is advised.
What if you forget to take Zoltias MD 0.25 Tablet :
Should you forget a Zoltias MD 0.25 Tablet dose, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Zoltias MD 0.25 Tablet
| Label | Value |
|---|---|
| Chemical Classification | Thienodiazepine Analog |
| Developing Habits | No. |
| Type of Therapy | Neuroscience, Central Nervous System |
| Actions | Benzodiazepine medications |


